Approval · Notice of Compliance 4652 · 1996
VENTODISK: Notice of Compliance 4652
Issued March 12, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4652
- Date
- March 12, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Bronchodilator, beta2-adrenergic stimulant
Products in this notice
Medicinal ingredients
- SALBUTAMOL SULFATE 200 MCG per BLD
- SALBUTAMOL SULFATE 400 MCG per BLD